A NOVEL SENOLYTIC NANOFORMULATION TARGETING THE HEPATIC SINUSOID IMPROVES HEPATIC FUNCTION AND FIBROSIS IN EXPERIMENTAL MODELS OF AGING

被引：0
|
作者：
Sanfeliu-Redondo, David [1 ]
Francisco, Vitor [2 ]
Tome, Ines [2 ,3 ]
Marques, Andreia [2 ,4 ]
Aristu, Peio [1 ,5 ]
Pitrez, Joao [2 ,6 ]
Rosa, Susana [2 ]
Ferreira, Lino [2 ,4 ]
Gracia-Sancho, Jordi [1 ,7 ]
机构：
[1] Hosp Clin Barcelona, Idibaps, Ciberehd, Barcelona, Spain
[2] Univ Coimbra, Cnc Ctr Neurosci & Cell Biol, Coimbra, Portugal
[3] Univ Coimbra, Fac Pharm, Coimbra, Portugal
[4] Univ Coimbra, Fac Med, Coimbra, Portugal
[5] BLB, Barcelona, Spain
[6] Inst Super Engn Coimbra, Coimbra, Portugal
[7] Univ Bern, Inselspital, Bern, Switzerland
来源：
HEPATOLOGY | 2023年 / 78卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
2614-A
引用
收藏
页码：S1256 / S1257
页数：2
相关论文
共 50 条
  • [41] ENDOGLIN DEFICIENCY IN HEPATIC STELLATE CELLS HAS A DIFFERENTIAL EFFECT ON LIVER FIBROSIS AND TGF-β SIGNALLING IN TWO EXPERIMENTAL MODELS OF MURINE LIVER FIBROSIS
    Alsamman, M.
    Weiskirchen, R.
    Wasmuth, H.
    Brenner, D.
    Trautwein, C.
    Scholten, D.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S60 - S60
  • [42] Targeting tissue inhibitor of metalloproteinase 1/2 using a shRNA lentiviral system offers a novel treatment strategy against hepatic fibrosis
    Zhang, Shouhua
    Liu, Queling
    Xiao, Juhua
    Lei, Jun
    Chai, Yong
    Liu, Yi
    Hong, Zhengdong
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL MEDICINE, 2016, 9 (12): : 23329 - 23336
  • [43] Hesperidin Supplementation Improves Altered PON -1, LDL Oxidation, Inflammatory Response and Hepatic Function in an Experimental Rat Model of Hyperlipidemia
    Raushan Kumar
    Mohammad Idreesh Khan
    Fauzia Ashfaq
    Abdulrahman A. Alsayegh
    Fahmida Khatoon
    Tahani Nasser Altamimi
    Syed Ibrahim Rizvi
    Indian Journal of Clinical Biochemistry, 2024, 39 : 257 - 263
  • [44] Pemafibrate improves hepatic inflammation, function and fibrosis in patients with non-alcoholic fatty liver disease: a one-year observational study
    Shinozaki, Satoshi
    Tahara, Toshiyuki
    Lefor, Alan Kawarai
    Ogura, Masahito
    CLINICAL AND EXPERIMENTAL HEPATOLOGY, 2021, 7 (02) : 172 - 177
  • [45] Anti-fibrotic effects of specific-siRNA targeting of the receptor for advanced glycation end products in a rat model of experimental hepatic fibrosis
    Cai, Xiao-Gang
    Xia, Jin-Rong
    Li, Wei-Dong
    Lu, Feng-Lin
    Liu, Juan
    Lu, Qin
    Zhi, Hong
    MOLECULAR MEDICINE REPORTS, 2014, 10 (01) : 306 - 314
  • [46] Hesperidin Supplementation Improves Altered PON-1, LDL Oxidation, Inflammatory Response and Hepatic Function in an Experimental Rat Model of Hyperlipidemia
    Kumar, Raushan
    Khan, Mohammad Idreesh
    Ashfaq, Fauzia
    Alsayegh, Abdulrahman A. A.
    Khatoon, Fahmida
    Altamimi, Tahani Nasser
    Rizvi, Syed Ibrahim
    INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY, 2024, 39 (02) : 257 - 263
  • [47] Hepatic stellate cell-targeted imatinib nanomedicine versus conventional imatinib: A novel strategy with potent efficacy in experimental liver fibrosis
    El-Mezayen, Nesrine S.
    El-Hadidy, Wessam F.
    El-Refaie, Wessam M.
    Shalaby, Th. I.
    Khattab, Mahmoud M.
    El-Khatib, Aiman S.
    JOURNAL OF CONTROLLED RELEASE, 2017, 266 : 226 - 237
  • [48] YH25724, a novel long-acting GLP-1/FGF21 dual agonist improves hepatic steatosis, inflammation and fibrosis in nonalcoholic steatohepatitis (NASH) animal models
    Kim, Jun Hwan
    Hong, Han Na
    Choi, Hyun Ho
    Kim, Dohoon
    Kim, Tae Wang
    Lim, Seyoung
    Seo, Minji
    Ju, Mi Kyeong
    Park, Ju-Young
    Choi, Byung Hyun
    Tolbol, Kirstine S.
    Feigh, Michael
    Vrang, Niels
    Kim, Jong Gyun
    Nam, Su Youn
    HEPATOLOGY, 2016, 64 (06) : 1136A - 1137A
  • [49] An angiotensin II type 1 receptor antagonist, olmesartan medoxomil, improves experimental liver fibrosis by suppression of proliferation and collagen synthesis in activated hepatic stellate cells
    Kurikawa, N
    Suga, M
    Kuroda, S
    Yamada, K
    Ishikawa, H
    BRITISH JOURNAL OF PHARMACOLOGY, 2003, 139 (06) : 1085 - 1094
  • [50] Novel chimeric natriuretic peptide CBA-NP reduces cardiorenal fibrosis and improves cardiorenal function in experimental diabetic rat model
    Ameenuddin, S.
    Oehler, E. A.
    Burnett, J. C., Jr.
    Chen, H. H.
    EUROPEAN HEART JOURNAL, 2011, 32 : 358 - 358
12345